Thyroid cancer is a form of cancer that develops from the tissues of the thyroid gland. The thyroid gland is located in the front of the throat, below the thyroid cartilage (also known as the Adam’s apple).
The thyroid gland produces several important hormones, including the thyroid hormone, which is involved in controlling body temperature, weight, energy level and heart rate. The thyroid gland also produces calcitonin, which helps the body use calcium.
Thyroid Cancer is a rare form of cancer representing about 1% of all cancers. It is the most common form of cancer affecting the endocrine system. Thyroid cancer is three times more common in females than in males, and the number of new cases has increased over recent years. The outlook for newly diagnosed patients is generally very good with 85% of patients surviving ten years. Initial treatment of thyroid cancer typically includes surgical removal of part or all of the thyroid gland, followed by treatment with radioiodine and replacement of thyroxin hormone. In patients whose cancer returns, additional surgery, radiation therapy and re-treatment with radioiodine are all commonly used strategies. However, there is a small number of patients whose recurrent cancer does not respond to radioiodine, and in these patients, the prognosis for long-term survival is significantly diminished. Unfortunately, there are few treatment options for these patients.
ThyCa: Thyroid Cancer Survivors’ Association
Thyroid Cancer Awareness Month is a worldwide observance, sponsored and initiated by ThyCa: Thyroid Cancer Survivors’ Association. It began in 2000, as a week in September. In 2003, it expanded to the whole month of September.
Thyroid Cancer Awareness Month listed in directories and references, including the American Hospital Association’s Calendar of Health Observances & Recognition Days.
Thyroid Cancer Awareness Month promotes thyroid cancer awareness for early detection, as well as care based on expert standards, and increased research to achieve cures for all thyroid cancer.
No comments:
Post a Comment
Tell us what you think!